Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles

Leon J. Khoza; Pradeep Kumar; Admire Dube; Patrick H. Demana; Yahya E. Choonara

doi:10.1016/j.ijpharm.2022.121893

Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles

Leon J. Khoza
, Pradeep Kumar
, Admire Dube
, Patrick H. Demana
, Yahya E. Choonara^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

15 Citations (Scopus)

Original language	English
Article number	121893
Journal	International Journal of Pharmaceutics
Volume	622
DOIs	https://doi.org/10.1016/j.ijpharm.2022.121893
Publication status	Published - 25 Jun 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Alveolar macrophages
Autophagy induction
Host-directed therapy
Innate immunity
Mycobacterium tuberculosis
Nanoparticles

Access to Document

10.1016/j.ijpharm.2022.121893

Cite this

@article{53f264fbbed347f7901ce2a430f814d6,

title = "Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles",

keywords = "Alveolar macrophages, Autophagy induction, Host-directed therapy, Innate immunity, Mycobacterium tuberculosis, Nanoparticles",

author = "Khoza, \{Leon J.\} and Pradeep Kumar and Admire Dube and Demana, \{Patrick H.\} and Choonara, \{Yahya E.\}",

note = "Funding Information: This work was supported by the National Research Foundation (NRF) South Africa [grant numbers: UID 64814 ]. The content is solely the authors' responsibility and does not necessarily represent the official views of the National Research Foundation.",

year = "2022",

month = jun,

day = "25",

doi = "10.1016/j.ijpharm.2022.121893",

language = "English",

volume = "622",

journal = "International Journal of Pharmaceutics",

issn = "0378-5173",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Insights into innovative therapeutics for drug-resistant tuberculosis

T2 - Host-directed therapy and autophagy inducing modified nanoparticles

AU - Khoza, Leon J.

AU - Kumar, Pradeep

AU - Dube, Admire

AU - Demana, Patrick H.

AU - Choonara, Yahya E.

N1 - Funding Information: This work was supported by the National Research Foundation (NRF) South Africa [grant numbers: UID 64814 ]. The content is solely the authors' responsibility and does not necessarily represent the official views of the National Research Foundation.

PY - 2022/6/25

Y1 - 2022/6/25

KW - Alveolar macrophages

KW - Autophagy induction

KW - Host-directed therapy

KW - Innate immunity

KW - Mycobacterium tuberculosis

KW - Nanoparticles

UR - https://www.scopus.com/pages/publications/85131744830

U2 - 10.1016/j.ijpharm.2022.121893

DO - 10.1016/j.ijpharm.2022.121893

M3 - Article

C2 - 35680110

AN - SCOPUS:85131744830

SN - 0378-5173

VL - 622

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

M1 - 121893

ER -

Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles

UN SDGs

Keywords

Access to Document

Other files and links

Cite this